Prevention and treatment

Vaccine availability

The USDA has granted Boehringer Ingelheim Vetmedica, Inc., a conditional license for ERAV with: Equine Rhinitis A Vaccine – Killed Virus.  It is available in 10 dose / 10 mL vials and pre-filled single dose syringes. A conditional license is eligible for consideration when it is demonstrated that there is a need in the field for such a product. The data required for conditional licensure includes demonstration of a reasonable expectation of efficacy, acceptable safety and purity requirements. Efficacy and potency studies are in progress. A conditionally licensed vaccine may be distributed as authorized in each state, and used by, or under the supervision of, veterinarians.

  • Incorporates the proprietary Ultrafil™ Purification Technology manufacturing process
  • Utilizes the Carbimmune™ adjuvant system
  • Administration and dosage: Shake well before use. Using aseptic technique, inoculate horse intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 1 mL dose in 3-4 weeks using the intramuscular route. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.

For more information:

  • Boehringer Ingelheim Vetmedica, Inc.

    Equine Division

    3902 Gene Field Road
    St. Joseph, Missouri 64506

    • Phone 866-638-2226
    • Fax 816-326-9167